연구동향 분석

EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia

Dan-Min Xu Yi-Lin Kong Li Wang Hua-Yuan Zhu Jia-Zhu Wu Yi Xia Yue Li Shu-Chao Qin Lei Fan Jian-Yong Li Jin-Hua Liang Wei Xu 2020년

논문상세정보
인용/피인용

' EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia' 의 참고문헌

  • microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma
    Imig J [2011]
  • Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia
    Roberts AW [2016]
  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia
    Baliakas P [2015]
  • Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia
    Burger JA [2019]
  • Prognostic impact of Epstein-Barr virus(EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemia
    Liang JH [2016]
  • Pathobiologic roles of Epstein-Barr virus-encoded microRNAs in human lymphomas
    Navari M [2018]
  • Lymphomas driven by Epstein-Barr virus nuclear antigen-1(EBNA1)are dependant upon Mdm2
    AlQarni S [2018]
  • Identification of virus-encoded microRNAs
    Pfeffer S [2004]
  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia : a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996guidelines
    Hallek M [2008]
  • Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia
    Tarrand JJ [2010]
  • Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival
    Visco C [2015]
  • EBV-encoded miRNAs
    Barth S [2011]
  • EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma
    Li Z [2012]
  • An international prognostic index for patients with chronic lymphocytic leukaemia(CLL-IPI) : a meta-analysis of individual patient data
  • Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus(EBV)-positive and EBVnegative Burkitt's lymphoma cells
    Renouf B [2009]
  • A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia
    Qiu J [2011]